Abstract
Protists causing human infections generally produce local or systemic disease through direct cellular injury, and inflammatory response. Some protists have been found associated with human neoplasms, and their carcinogenic potential has received much attention in recent years. Here we outline the epidemiologic and experimental evidence linking Cryptosporidium sp., malaria and Trichomonas vaginalis to neoplastic changes in humans. Experimental studies in mammalian cells have unraveled the disruptive alterations in many of the normal signaling pathways that are critical in innate and adaptive immunity. The immune deficient states, induced by protists or other concurrent infections, most likely increase susceptibility to infection and contribute to tumorigenesis. The neoplasms that occur in malaria and trichomoniasis often contain Epstein-Barr virus (EBV) and human papilloma virus (HPV), respectively. The relative contribution of protists and different viruses, including HIV, requires delineation. The role of local microbiota in determining susceptibility to Cryptosporidium sp. or T. vaginalis infection and in carcinogenesis also requires additional investigation. The elucidation of precise mechanisms of tumorigenesis in mono- and polymicrobial infections is expected to identify targets for intervention and treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BL:
-
Burkitt’s lymphoma
- COX-2:
-
Cyclooxygenase-2
- EBV :
-
Epstein-Barr virus
- NF-κB:
-
nuclear factor κB
- SCID:
-
severe combined immunodeficiency
References
Introduction
Benamrouz S, Conseil V, Creusy C et al (2012) Parasites and malignancies, a review, with emphasis on digestive cancer induced by Cryptosporidium parvum (Alveolata: Apicomplexa). Parasite 19:101–115
Blaser MJ (2008) Understanding microbe-induced cancers. Cancer Prev Res (Phila) 1:15–20
IARC (2014) International agency for research on cancer. Agents classified by the IARC monographs, vol 1–110. World Health Organization, Geneva
Kutikhin AG, Yuzhalin AE, Brusina EB (2013) The role of protozoa in cancer development. In: Kutikhin AG et al (eds) Infectious agents and cancer. Springer, Berlin
Cryptosporidium sp.
Abdou AG, Harba NM, Afifi AF, Elnaidany NF (2013) Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia. Int J Infect Dis 17:e593–e600
Abrahamsen MS, Templeton TJ, Enomoto S et al (2004) Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 304:441–445
Benamrouz S, Conseil V, Chabé M et al (2014) Cryptosporidium parvum-induced ileo-caecal adenocarcinoma and Wnt signaling in a mouse model. Dis Model Mech 7:693–700
Certad G, Ngouanesavanh T, Guyot K et al (2007) Cryptosporidium parvum, a potential cause of colic adenocarcinoma. Infect Agent Cancer 2:22
Certad G, Creusy C, Guyot K et al (2010a) Fulminant cryptosporidiosis associated with digestive adenocarcinoma in SCID mice infected with Cryptosporidium parvum TUM1 strain. Int J Parasitol 40:1469–1475
Certad G, Creusy C, Ngouanesavanh T et al (2010b) Development of Cryptosporidium parvum-induced gastrointestinal neoplasia in severe combined immunodeficiency (SCID) mice: severity of lesions is correlated with infection intensity. Am J Trop Med Hyg 82:257–265
Certad G, Benamrouz S, Guyot K et al (2012) Fulminant cryptosporidiosis after near-drowning: a human Cryptosporidium parvum strain implicated in invasive gastrointestinal adenocarcinoma and cholangiocarcinoma in an experimental model. Appl Environ Microbiol 78:1746–1751
Chalmers RM, Davis AP (2010) Minireview: clinical cryptosporidiosis. Exp Parasitol 124:138–146
Chen X-M, Levine SA, Tietz P et al (1998) Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 28:906–913
Chen X-M, Gores GJ, Paya CV, LaRusso NF (1999) Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol 277:G599–G608
Chen X-M, Levine SA, Splinter PL et al (2001) Cryptosporidium parvum activates nuclear factor κB in biliary epithelia preventing epithelial cell apoptosis.Gastroenterology 120:1774-1783
Cowman AF, Kappe SHI (2013) Malaria’s stealth shuttle. Science 313:1287–1290
Current WL, Reese NC, Ernst JV et al (1983) Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N Engl J Med 308:1252–1257
Goebel E, Braendler U (1982) Ultrastructure of microgametogenesis, microgametes and gametogamy of Cryptosporidium sp. in the small intestine of mice. Protistologica 18:331–334
Heussler VT, Küenzi P, Rottenberg S (2001) Inhibition of apoptosis by intracellular protozoan parasites. Int J Parasitol 31:1166–1176
Izquierdo J, Antúnez I, Calderón MT et al (1988) Diarrhea caused by Cryptosporidium and colonic neoplasia. Rev Clin Esp 182:393–394
Lasser KH, Lewin KJ, Ryning FW (1979) Cryptosporidial enteritis in a patient with congenital hypogammaglobulinemia. Hum Pathol 10:234–240
Liu J, Enomoto S, Lancto CA et al (2008) Inhibition of apoptosis in Cryptosporidium parvum-infected intestinal epithelial cells is dependent on survivin. Infect Immun 76:3784–3792
Liu J, Deng M, Lancto CA et al (2009) Biphasic modulation of apoptotic pathways in Cryptosporidium parvum-infected human intestinal epithelial cells. Infect Immun 77(2):837–849
López-Vélez R, Tarazona R, Garcia Camacho A et al (1995) Intestinal and extraintestinal cryptosporidiosis in AIDS patients. Eur J Clin Microbiol Infect Dis 14:677–681
Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21:485–495
Meisel JL, Perera DR, Meligro C, Rubin CE (1976) Overwhelming watery diarrhea associated with Cryptosporidium in an immunosuppressed patient. Gastroenterology 70:1156–1160
Nash PB, Purner MB, Leon RP et al (1998) Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol 160:1824–1830
Naugler WE, Karin M (2008) NF-κB and cancer – identifying targets and mechanisms. Curr Opin Genet Dev 18:19–26
O’Hara SP, Chen X-M (2011) The cell biology of cryptosporidium [sic] infection. Microbes Infect 13:721–730
O’Hara SP, Small AJ, Gajdos GB et al (2009) HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum. J Infect Dis 199:1195–1204
Orenstein JM, Dieterich DT (2001) The histopathology of 103 consecutive colonoscopy biopsies from 82 symptomatic patients with acquired immunodeficiency syndrome: original and look-back diagnoses. Arch Pathol Lab Med 125:1042–1046
Patel P, Hanson DL, Sullivan PS et al (2008) Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 148:728–736
Ramirez NE, Ward LA, Sreevatsan S (2004) A review of the biology and epidemiology of cryptosporidiosis in humans and animals. Microbes Infect 6:773–785
Semenza JC, Nichols G (2007) Cryptosporidiosis surveillance and water-borne outbreaks in Europe. Euro Surveill 12:E13–E14
Shebl FM, Engels EA, Goedert JJ (2012) Opportunistic intestinal infections and risk of colorectal cancer among people with AIDS. AIDS Res Hum Retroviruses 28:994–999
Snelling WJ, Lin Q, Moore JE et al (2007) Proteomics analysis and protein expression during sporozoite excystation of Cryptosporidium parvum (Coccidia, Apicomplexa). Mol Cell Proteomics 6:346–355
Stephens J, Cosyns M, Jones M, Hayward A (1999) Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice. Hepatology 30:27–35
Sturm A, Amino R, van de Sand C et al (2013) Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313:1287–1290
Sulzyc-Bielicka V, Kuźna-Grygiel W, Kolodziejczyk L et al (2007) Cryptosporidiosis in patients with colorectal cancer. J Parasitol 93:722–724
Sulźyc-Bielicka V, Kolodziejczyk L, Jaczewska S et al (2012) Prevalence of Cryptosporidium sp. in patients with colorectal cancer. Pol Przegl Chir 84:348–351
Takahashi M, Mutoh M, Kawamori T et al (2000) Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 21:1319–1327
Valigurová A, Jirku M, Koudela B et al (2008) Cryptosporidia: epicellular parasites embraced by the host cell membrane. Int J Parasitol 38:913–922
Weisburger WR, Hutcheon DF, Yardley JH et al (1979) Cryptosporidiosis in an immunosuppressed renal-transplant recipient with IgA deficiency. Am J Clin Pathol 72:473–478
Xu P, Widmer G, Wang Y et al (2004) The genome of Cryptosporidium hominis. Nature 431:1107–1112
Malaria
Burkitt D (1958) A sarcoma involving the jaws in African children. Br J Surg 46:218–223
Burkitt DP (1969) Etiology of Burkitt’s lymphoma – an alternative hypothesis to a vectored virus. J Natl Cancer Inst 42:19–28
Burkitt D, Wright D (1966) Geographical and tribal distribution of the African Lymphoma in Uganda. Br Med J 1:569–573
Dalla-Favera R, Bregni M, Erikson J et al (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79:7824–7827
de The G (1979) The epidemiology of Burkitt’s lymphoma: evidence for a causal association with Epstein-Barr virus. Epidemiol Rev 1:32–54
de The G (1993) The etiology of Burkitt’s lymphoma and the history of the shaken dogmas. Blood Cells 19:667–673
de The G, Geser A, Day NE et al (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature 274:756–761
Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1:702–703
Evans AS (1985) Epidemiology of Burkitt’s lymphoma: other risk factors. IARC Sci Publ 60:197–204
Greenwood BM (1974) Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet 1:435–436
Henle W, Henle G (1974) The Epstein-Barr virus in Burkitt’s lymphoma and nasopharyngeal carcinoma. Ann Clin Lab Sci 4:109–114
Henle G, Henle W, Clifford P et al (1969) Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups. J Natl Cancer Inst 43:1147–1157
Jayasooriya S, Hislop A, Peng Y et al (2012) Revisiting the effect of acute P. falciparum malaria on Epstein-Barr virus: host balance in the setting of reduced malaria endemicity. PLoS One 7:e31142
Kafuko GW (1969) Association of Burkitt’s tumour and holoendemic malaria in the West Nile district, Uganda: malaria as a possible etiologic factor. E Afr Med J 46:414–436
Klein U, Dalla-Favera R (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8:22–33
Lam KM, Syed N, Whittle H, Crawford DH (1991) Circulating Epstein-Barr virus–carrying B cells in acute malaria. Lancet 337:876–878
Mannucci S, Luzzi A, Carugi A et al (2012) EBV reactivation and chromosomal polysomies: euphorbia tirucalli as a possible cofactor in endemic Burkitt lymphoma. Adv Hematol 2012:149780
Manolov G, Manolova Y (1972) Marker band in one chromosome 14 from Burkitt lymphomas. Nature 237:33–34
Mbulaiteye SM (2013) Burkitt lymphoma: beyond discoveries. Infect Agent Cancer 8:35–38
Molyneux EM, Rochford R, Griffin B et al (2012) Burkitt’s lymphoma. Lancet 379:1234–1244
Moormann AM, Chelimo K, Sumba OP et al (2005) Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 191:1233–1238
Mutalima N, Molyneux E, Jaffe H et al (2008) Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One 3:e2505
Newton R, Ziegler J, Beral V et al (2001) A case–control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 92:622–627
Orem J, Mbidde EK, Lambert B et al (2007) Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci 7:166–175
Osato T (1998) Epstein-Barr virus infection and oncogenesis. In: Epstein-Barr virus and human cancer. Gann Monograph on Cancer Research no. 45. Japanese Cancer Association, Japan Scientific Societies Press, Tokyo, Karger, Basel, Switzerland, pp 7–11
Snider CJ, Cole SR, Chelimo K et al (2012) Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens. PLoS One 7:e31753
Torgbor C, Awuah P, Deitsch K et al (2014) A Multifactorial role for P. falciparum malaria in endemic Burkitt’s lymphoma pathogenesis. PLoS Pathog 10:e1004170
WHO (2013) http://www.who.int/malaria/media/world_malaria_report_2013/en/. World Health Organization, Geneva
Zur Hausen H, Schulte-Holthausen H, Klein G et al (1970) EBV-DNA in biopsies of Burkitt’s tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056–1058
Trichomonas vaginalis
Allaj V, Guo C, Nie D (2013) Non-steroid anti-inflammatory drugs, prostaglandins, and cancer. Cell Biosci 3:8
Allsworth JE, Ratner JA, Peipert JF (2009) Trichomoniasis and other sexually transmitted infections: results from the 2001–2004 National Health and Nutrition Examination Surveys. Sex Transm Dis 36:738–744
Alsmark C, Foster PG, Sicheritz-Ponten T et al (2013) Effect of HIV-1 Vpr on cell cycle regulators. Patterns of prokaryotic lateral gene transfers affecting parasitic microbial eukaryotes. Genome Biol 14:R19
Amini S, Khalili K, Sawaya BE (2004) Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol 23:249–260
Azevedo A, Cunha V, Teixeira AL, Medeiros R (2011) IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol 2:384–396
Bachmann LH, Hobbs MM, Seña AC et al (2011) Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis 53(Suppl 3):S160–S172
Brotman RM, Bradford LL, Conrad M et al (2012) Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women. Sex Transm Dis 39:807–812
Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148:1258–1270
Cotch MF, Pastorek JG 2nd, Nugent RP et al (1997) Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 24:353–360
Cowan MJ, Coll T, Shelhamer JH (2006) Polyamine-mediated reduction in human airway epithelial migration in response to wounding is PGE2 dependent through decreases in COX-2 and cPLA2 protein levels. J Appl Physiol 101:1127–1135
Dhanasekaran SM, Barrette TR, Ghosh D et al (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412:822–826
Dubois RN, Abramson SB, Crofford L et al (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063–1073
Fichorova RN, Trifonova RT, Gilbert RO et al (2006) Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 74:5773–5779
Garcia AF, Benchimol M, Alderete JF (2005) Trichomonas vaginalis polyamine metabolism is linked to host cell adherence and cytotoxicity. Infect Immun 73:2602–2610
Gardner WA Jr, Culberson DE, Bennett BD (1986) Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 110:430–432
Gram IT, Macaluso M, Churchill J, Stalsberg H (1992) Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control 3:231–236
Han IH, Park SJ, Ahn MH, Ryu JS (2012) Involvement of mast cells in inflammation induced by Trichomonas vaginalis via crosstalk with vaginal epithelial cells. Parasite Immunol 34:8–14
Hirt RP (2013) Trichomonas vaginalis virulence factors: an integrative overview. Sex Transm Infect 89:439–443
Hirt RP, de Miguel N, Nakjang S et al (2011) Trichomonas vaginalis pathobiology: new insights from the genome sequence. Adv Parasitol 77:87–140
Hobbs MM, Sena AC, Swygard H et al (2008) Trichomonas vaginalis and trichomoniasis. In: Holmes K et al (eds) Sexually transmitted diseases, 4th edn. McGraw-Hill, New York, pp 771–793
Hughes JP, Baeten JM, Lingappa JR et al (2012) Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 205:358–365
Kucknoor AS, Mundodi V, Alderete JF (2007) The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65. Cell Microbiol 9:2586–2597
Lazenby GB, Taylor PT, Badman BS et al (2014) An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther 36:38–45
Magnuson NS, Wang Z, Ding G, Reeves R (2010) Why target PIM1 for cancer diagnosis and treatment? Future Oncol 6:1461–1478
Miller WC, Swygard H, Hobbs MM et al (2005) The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 32:593–598
Mitteregger D, Aberle SW, Makristathis A et al (2012) High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue. Med Microbiol Immunol 201:113–116
Moodley P, Wilkinson D, Connolly C et al (2002) Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 34:519–522
Morada M, Manzur M, Lam B et al (2010) Arginine metabolism in Trichomonas vaginalis infected with Mycoplasma hominis. Microbiology 156:3734–3743
Muzny CA, Blackburn RJ, Sinsky RJ et al (2014) Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 59:834–841
Reeves R, Beckerbauer L (2001) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519:13–29
Roh M, Franco OE, Hayward SW et al (2008) A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. PLoS One 3:e2572
Rughooputh S, Greenwell P (2005) Trichomonas vaginalis: paradigm of a successful sexually transmitted organism. Br J Biomed Sci 62:193–200
Ryan CM, de Miguel N, Johnson PJ (2011) Trichomonas vaginalis: current understanding of host-parasite interactions. Essays Biochem 51:161–175
Ryu JS, Kang JH, Jung SY et al (2004) Production of interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect Immun 72:1326–1332
Sansone P, Bromberg J (2012) Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 30:1005–1014
Satterwhite CL, Torrone E, Meites E et al (2013) Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 40:187–193
Sayed el-Ahl SA, el-Wakil HS, Kamel NM, Mahmoud MS (2002) A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women. J Egypt Soc Parasitol 32:167–178
Shaio MF, Lin PR, Liu JY, Tang KD (1994) Monocyte-derived interleukin-8 involved in the recruitment of neutrophils induced by Trichomonas vaginalis infection. J Infect Dis 170:1638–1640
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29
Stark JR, Judson G, Alderete JF et al (2009a) Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: physicians’ health study. J Natl Cancer Inst 101:1406–1411
Stark JR, Li H, Kraft P et al (2009b) Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer 124:2683–2689
Sutcliffe S, Giovannucci E, Alderete JF et al (2006) Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15:939–945
Sutcliffe S, Neace C, Magnuson NS et al (2012) Trichomonosis, a common curable STI, and prostate carcinogenesis – a proposed molecular mechanism. PLoS Pathog 8:e1002801
Tesfaye A, Di Cello F, Hillion J et al (2007) The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res 67:3998–4004
Twu O, de Miguel N, Lustig G et al (2013) Trichomonas vaginalis exosomes deliver cargo to host cells and mediate host: parasite interactions. PLoS Pathog 9:e1003482
Valdman A, Fang X, Pang ST et al (2004) Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer. Prostate 60:367–371
WHO (2011) Prevalence and incidence of selected sexually transmitted infections: Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis, and Trichomonas vaginalis. Methods and results used by the WHO to generate 2005 estimates. World Health Organization, Geneva
Zhang ZF, Begg CB (1994) Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 23:682–690
Zhang ZF, Graham S, Yu SZ et al (1995) Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol 5:325–332
Zhang Y, Wang Z, Li X, Magnuson NS (2008) Pim kinase-dependent inhibition of c-Myc degradation. Oncogene 27:4809–4819
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gupta, R., Nowakowski, M., Haseeb, M.A. (2015). Human Protozoal Infections and Their Potential for Causing Neoplasms. In: Shurin, M., Thanavala, Y., Ismail, N. (eds) Infection and Cancer: Bi-Directorial Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-20669-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-20669-1_5
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20668-4
Online ISBN: 978-3-319-20669-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)